Skip to Main Content

Paper Details

Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.
JAMA Netw Open
30
2020
CYP2C19, CYP2D6, Participants, Patients, Pediatric, amitriptyline, children, citalopram, codeine, escitalopram, genes, ondansetron, oxycodone, patients, pediatric, tramadol
Author NameAffiliation
Jonathan S SchildcroutVanderbilt University Medical Center
Yaping ShiVanderbilt University Medical Center
James K HicksH. Lee Moffitt Cancer Center and Research Institute
Nihal El RoubyDepartment of Pharmacotherapy and Translational Research, University of Florida
Nihal El RoubyUniversity of Cincinnati
Larisa H CavallariDepartment of Pharmacotherapy and Translational Research, University of Florida
Sony TutejaPerelman School of Medicine, University of Pennsylvania
Amber L BeitelsheesUniversity of Maryland
James J CiminoInformatics Institute, University of Alabama at Birmingham.
James J CiminoInformatics Institute, University of Alabama at Birmingham.
Nita A LimdiUniversity of Alabama at Birmingham.
Christopher M HorvatUniversity of Pittsburgh
Gloria LiporiUniversity of Florida Health and University of Florida Health Sciences Center
Marc B RosenmanIndiana University School of Medicine
Marc B RosenmanAnn & Robert H. Lurie Children's Hospital of Chicago
Aniwaa Owusu ObengThe Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai
Josh F PetersonVanderbilt University Medical Center
Sara L Van DriestVanderbilt University Medical Center
Sara L Van DriestVanderbilt University Medical Center
  • 1 - 19

Datasets

Release 1.2